Nothing Special   »   [go: up one dir, main page]

ZA200800125B - Promotion of epithelial regeneration - Google Patents

Promotion of epithelial regeneration

Info

Publication number
ZA200800125B
ZA200800125B ZA200800125A ZA200800125A ZA200800125B ZA 200800125 B ZA200800125 B ZA 200800125B ZA 200800125 A ZA200800125 A ZA 200800125A ZA 200800125 A ZA200800125 A ZA 200800125A ZA 200800125 B ZA200800125 B ZA 200800125B
Authority
ZA
South Africa
Prior art keywords
promotion
epithelial regeneration
epithelial
regeneration
Prior art date
Application number
ZA200800125A
Other languages
English (en)
Inventor
Ferguson Mark
Laverty Hugh
O'kane Sharon
Occleston Nick
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Publication of ZA200800125B publication Critical patent/ZA200800125B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ZA200800125A 2005-07-12 2008-01-04 Promotion of epithelial regeneration ZA200800125B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0514262.5A GB0514262D0 (en) 2005-07-12 2005-07-12 Promotion of epithelial regeneration

Publications (1)

Publication Number Publication Date
ZA200800125B true ZA200800125B (en) 2008-12-31

Family

ID=34897090

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200800125A ZA200800125B (en) 2005-07-12 2008-01-04 Promotion of epithelial regeneration

Country Status (12)

Country Link
US (1) US20080207515A1 (xx)
EP (2) EP1904089A2 (xx)
JP (1) JP2009501201A (xx)
KR (1) KR20080031405A (xx)
CN (1) CN101252949A (xx)
AU (1) AU2006268091C1 (xx)
BR (1) BRPI0613127A2 (xx)
CA (1) CA2614758A1 (xx)
GB (1) GB0514262D0 (xx)
IL (1) IL188351A0 (xx)
WO (1) WO2007007098A2 (xx)
ZA (1) ZA200800125B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0514262D0 (en) 2005-07-12 2005-08-17 Renovo Ltd Promotion of epithelial regeneration
GB0604964D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Protein folding
GB0604938D0 (en) 2006-03-11 2006-04-19 Renovo Ltd Proteins, nucleic acids and medicaments
GB0604966D0 (en) * 2006-03-11 2006-04-19 Renovo Ltd Medicaments and proteins
GB0724204D0 (en) * 2007-12-12 2008-01-23 Renovo Ltd Methods for inhibition of scarring
GB0724203D0 (en) * 2007-12-12 2008-01-23 Renovo Ltd Methods for the inhibition of scarring
GB0910078D0 (en) * 2009-06-11 2009-07-22 Renovo Ltd Uses of mannose-6-phosphate
EP2637697A4 (en) 2010-11-12 2016-07-13 Cour Pharmaceuticals Dev Company MODIFIED IMMUNOMODULATING PARTICLES
CN104684578B (zh) 2012-06-21 2019-04-19 西北大学 肽缀合粒子
IL303425A (en) 2013-03-13 2023-08-01 Cour Pharmaceuticals Dev Company Secondary vaccine particles for the treatment of inflammation
KR102485789B1 (ko) 2013-08-13 2023-01-05 노쓰웨스턴유니버시티 펩티드-접합된 입자
WO2015138502A1 (en) * 2014-03-11 2015-09-17 Gary Cleary In-situ skin regeneration for epidermolysis bullosa and other skin disorders
WO2015195845A1 (en) 2014-06-17 2015-12-23 Xycrobe Therapeutics, Inc. Genetically modified bacteria and methods for genetic modification of bacteria
US11504404B2 (en) 2016-02-24 2022-11-22 Crown Laboratories, Inc. Skin probiotic formulation
KR102313197B1 (ko) * 2018-07-11 2021-10-18 강형철 고체상염의 삼투작용으로 수포형성을 억제하는 화상 응급처치용 치료 제제 및 이를 포함하는 패치
CA3183350A1 (en) 2020-06-23 2021-12-30 Thomas M. Hitchcock Probiotic skin formulations
US20240173561A1 (en) 2021-05-21 2024-05-30 Emblation Limited Microwave treatment of tissue

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051848A (en) * 1976-03-01 1977-10-04 Levine Norman S Synthetic skin wound dressing
US6559123B1 (en) * 1985-04-19 2003-05-06 Osi Pharmaceuticals, Inc. Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
NZ222168A (en) 1986-10-20 1991-05-28 Oncogene Science Inc Tumour growth inhibiting protein related to tgf-#b#1 and tgf-#b#2, preparation by genetic engineering methods, antibodies and pharmaceutical compositions
US5135915A (en) * 1988-10-14 1992-08-04 Genentech, Inc. Method for the treatment of grafts prior to transplantation using TGF-.beta.
GB8927546D0 (en) * 1989-12-06 1990-02-07 Ciba Geigy Process for the production of biologically active tgf-beta
US6054122A (en) * 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
GB9206861D0 (en) * 1992-03-28 1992-05-13 Univ Manchester Wound healing and treatment of fibrotic disorders
AU3943793A (en) * 1992-04-01 1993-11-08 Whittier Institute For Diabetes And Endocrinology, The Methods of inhibiting or enhancing scar formation in the CNS
US5411940A (en) * 1993-09-29 1995-05-02 Alcon Laboratories, Inc. Use of TGF-β3 to reduce the formation of scar tissue in response to corneal trauma
TW440566B (en) * 1994-07-25 2001-06-16 Novartis Ag Novel process for the production of biologically active dimeric protein
EP0914168A1 (en) * 1996-05-03 1999-05-12 Innogenetics N.V. New medicaments containing gelatin cross-linked with oxidized polysaccharides
EP1074620A1 (en) * 1999-08-06 2001-02-07 HyGene AG Monomeric protein of the TGF-beta family
AU3556400A (en) * 1999-03-17 2000-10-04 Novartis Ag Pharmaceutical compositions
ES2283399T3 (es) * 2000-04-25 2007-11-01 Otsuka Pharmaceutical Co., Ltd. Peptidomimetico de gd3.
US20040078851A1 (en) * 2000-05-02 2004-04-22 Ning Huang Production of human growth factors in monocot seeds
WO2002076494A2 (en) * 2001-03-23 2002-10-03 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh USE OF CYTOKINES OF THE TGF-β SUPERFAMILY FOR THE TREATMENT AND DIAGNOSIS OF SKIN RELATED DISORDERS
JP2009501200A (ja) * 2005-07-12 2009-01-15 レノボ・リミテッド ＴＧＦ−βスーパーファミリーメンバーを含有する医薬組成物
GB0514262D0 (en) 2005-07-12 2005-08-17 Renovo Ltd Promotion of epithelial regeneration

Also Published As

Publication number Publication date
US20080207515A1 (en) 2008-08-28
WO2007007098A3 (en) 2007-05-18
AU2006268091A1 (en) 2007-01-18
EP2298336A2 (en) 2011-03-23
AU2006268091B2 (en) 2010-09-02
GB0514262D0 (en) 2005-08-17
AU2006268091C1 (en) 2011-03-31
WO2007007098A2 (en) 2007-01-18
BRPI0613127A2 (pt) 2010-12-21
KR20080031405A (ko) 2008-04-08
EP1904089A2 (en) 2008-04-02
EP2298336A3 (en) 2011-07-13
JP2009501201A (ja) 2009-01-15
CA2614758A1 (en) 2007-01-18
CN101252949A (zh) 2008-08-27
EP2298336A9 (en) 2011-06-01
IL188351A0 (en) 2008-04-13

Similar Documents

Publication Publication Date Title
IL188351A0 (en) Promotion of epithelial regeneration
ZA200900305B (en) Dressing
IL186594A0 (en) Nebuliser
ZA200808372B (en) Antibody purification
IL186492A0 (en) Nebuliser
HUE042689T2 (hu) TGFbéta elleni antitestek
GB0610553D0 (en) Dressing
PT2011869E (pt) Novo anticorpo anti-cd98
GB0611116D0 (en) Proteins
EP1869192A4 (en) FRAME MIXTURE OF ANTIBODIES
IL185757A0 (en) Methods of decreasing calcifcation
GB0601976D0 (en) Proteins
GB0620735D0 (en) Proteins
DE502006007368D1 (de) Fördervorrichtung
EP2121726A4 (en) PROTEIN PARTICLE
GB0623196D0 (en) Dressing
EP2024516A4 (en) Perforin-2 PROTEINS
GB0606021D0 (en) Discharge lamp
DE602005013361D1 (de) Pneumatischer filter
GB0518232D0 (en) New methods
GB0614682D0 (en) Proteins
GB0612623D0 (en) Proteins
GB0501638D0 (en) Particulates
AU2005906217A0 (en) Methods for Promotion
SE0401263D0 (sv) New particles